Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Bisphosphonate Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Bisphosphonate Drug Industry
  • 1.7 COVID-19 Impact: Bisphosphonate Drug Market Trends

    • 2 Global Bisphosphonate Drug Quarterly Market Size Analysis

    • 2.1 Bisphosphonate Drug Business Impact Assessment - COVID-19
      • 2.1.1 Global Bisphosphonate Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Bisphosphonate Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Bisphosphonate Drug Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Bisphosphonate Drug Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Bisphosphonate Drug Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Bisphosphonate Drug Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Bisphosphonate Drug Market
    • 3.5 Key Manufacturers Bisphosphonate Drug Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Bisphosphonate Drug Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Alendronate
      • 1.4.2 Risedronate
      • 1.4.3 Zoledronic acid
      • 1.4.4 Other Bisphosphonate Drug
    • 4.2 By Type, Global Bisphosphonate Drug Market Size, 2019-2021
      • 4.2.1 By Type, Global Bisphosphonate Drug Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Bisphosphonate Drug Price, 2020-2021

    5 Impact of Covid-19 on Bisphosphonate Drug Segments, By Application

    • 5.1 Overview
      • 5.5.1 Postmenopausal osteoporosis
      • 5.5.2 Men with osteoporosis
      • 5.5.3 Paget’s disease
      • 5.5.4 Bone loss caused by cancer treatment
      • 5.5.5 Osteoporosis imperfecta in children
    • 5.2 By Application, Global Bisphosphonate Drug Market Size, 2019-2021
      • 5.2.1 By Application, Global Bisphosphonate Drug Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Bisphosphonate Drug Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Merck
      • 7.1.1 Merck Business Overview
      • 7.1.2 Merck Bisphosphonate Drug Quarterly Production and Revenue, 2020
      • 7.1.3 Merck Bisphosphonate Drug Product Introduction
      • 7.1.4 Merck Response to COVID-19 and Related Developments
    • 7.2 Teva
      • 7.2.1 Teva Business Overview
      • 7.2.2 Teva Bisphosphonate Drug Quarterly Production and Revenue, 2020
      • 7.2.3 Teva Bisphosphonate Drug Product Introduction
      • 7.2.4 Teva Response to COVID-19 and Related Developments
    • 7.3 Mylan
      • 7.3.1 Mylan Business Overview
      • 7.3.2 Mylan Bisphosphonate Drug Quarterly Production and Revenue, 2020
      • 7.3.3 Mylan Bisphosphonate Drug Product Introduction
      • 7.3.4 Mylan Response to COVID-19 and Related Developments
    • 7.4 Apotex Corp
      • 7.4.1 Apotex Corp Business Overview
      • 7.4.2 Apotex Corp Bisphosphonate Drug Quarterly Production and Revenue, 2020
      • 7.4.3 Apotex Corp Bisphosphonate Drug Product Introduction
      • 7.4.4 Apotex Corp Response to COVID-19 and Related Developments
    • 7.5 Cobalt Pharmaceuticals
      • 7.5.1 Cobalt Pharmaceuticals Business Overview
      • 7.5.2 Cobalt Pharmaceuticals Bisphosphonate Drug Quarterly Production and Revenue, 2020
      • 7.5.3 Cobalt Pharmaceuticals Bisphosphonate Drug Product Introduction
      • 7.5.4 Cobalt Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.6 Genentech
      • 7.6.1 Genentech Business Overview
      • 7.6.2 Genentech Bisphosphonate Drug Quarterly Production and Revenue, 2020
      • 7.6.3 Genentech Bisphosphonate Drug Product Introduction
      • 7.6.4 Genentech Response to COVID-19 and Related Developments
    • 7.7 Novartis Pharmaceuticals
      • 7.7.1 Novartis Pharmaceuticals Business Overview
      • 7.7.2 Novartis Pharmaceuticals Bisphosphonate Drug Quarterly Production and Revenue, 2020
      • 7.7.3 Novartis Pharmaceuticals Bisphosphonate Drug Product Introduction
      • 7.7.4 Novartis Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.8 Sanofi-Aventis
      • 7.8.1 Sanofi-Aventis Business Overview
      • 7.8.2 Sanofi-Aventis Bisphosphonate Drug Quarterly Production and Revenue, 2020
      • 7.8.3 Sanofi-Aventis Bisphosphonate Drug Product Introduction
      • 7.8.4 Sanofi-Aventis Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Bisphosphonate Drug Supply Chain Analysis
      • 8.1.1 Bisphosphonate Drug Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Bisphosphonate Drug Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Bisphosphonate Drug Distribution Channels
      • 8.2.2 Covid-19 Impact on Bisphosphonate Drug Distribution Channels
      • 8.2.3 Bisphosphonate Drug Distributors
    • 8.3 Bisphosphonate Drug Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Bisphosphonate Drug, including the following market information:
      Global Bisphosphonate Drug Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Bisphosphonate Drug Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Bisphosphonate Drug Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Bisphosphonate Drug Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

      Key market players
      Major competitors identified in this market include Merck, Teva, Mylan, Apotex Corp, Cobalt Pharmaceuticals, Genentech, Novartis Pharmaceuticals, Sanofi-Aventis, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Alendronate
      Risedronate
      Zoledronic acid
      Other Bisphosphonate Drug

      Based on the Application:
      Postmenopausal osteoporosis
      Men with osteoporosis
      Paget’s disease
      Bone loss caused by cancer treatment
      Osteoporosis imperfecta in children

      Buy now